Overview
Salesforce Inc reported fiscal second-quarter results that materially beat analyst expectations and led management to lift full-year EPS guidance. Adjusted EPS came in at $5.90 versus a $3.27 consensus, while free cash flow rose 81% year-over-year to $1.1 billion. The company also announced an increase to full-year EPS guidance by roughly $2.60 to a range of $16.67 to $16.71, and the stock reacted strongly to the news.
Headline and underlying performance
Top-line revenue for the period was $11.35 billion, up 11% year-over-year. That revenue figure was marginally above consensus, but several beneath-the-surface metrics carried the most weight for investors. Salesforce reported a current Remaining Performance Obligation, or cRPO, growth of 14% in constant currency - the fastest pace the company has posted in four years - which suggests a growing backlog of future revenue. Management guided Q3 cRPO to about 14% as well, roughly one percentage point above Street expectations.
Key metrics versus expectations
- Adjusted EPS: $5.90 versus $3.27 estimate - roughly an 80% beat.
- Revenue: $11.35 billion versus $11.32 billion estimate - about a 0.3% surprise.
- Free cash flow: $1.1 billion versus $643 million estimate - roughly a 71% surprise to the upside.
- cRPO growth (constant currency): 14% versus 10% estimate - a 4 percentage point beat.
AI monetization is showing up in the numbers
Salesforce said Agentforce annual recurring revenue (ARR) reached $1.5 billion, expanding more than 240% year-over-year. Combined with other AI and data products, including Data 360 and Informatica, the total AI/data ARR stood at $3.9 billion, up 210% year-over-year. Management highlighted that roughly half of bookings for these offerings came from existing customers expanding their commitments. The company also noted premium SKU bookings where more than 60% were expansions by existing customers, indicating that upsell from the installed base is a primary driver of AI-related revenue growth.
Claudeforce and the Anthropic tie-up
A notable product announcement was "Claudeforce," an AI plug-in developed with Anthropic that places Claude’s reasoning and decision-making capabilities on top of Salesforce’s enterprise data, workflows, and permission model. Market analysts responded by adjusting price targets: TD Cowen raised its target to $280 from $240 and described the partnership as a potential trajectory changer for 2027, while Jefferies increased its target to $300 and pointed to talent movement - sales executives returning from AI labs - as a signal that often precedes product breakthroughs.
Investor questions addressed
The quarter answered several core investor concerns:
- Is AI producing measurable revenue? Management presented Agentforce ARR at $1.5 billion with 240% growth and noted substantial expansion bookings from existing customers.
- Can growth re-accelerate? The 14% cRPO growth and guidance for sustained cRPO near that level suggest revenue momentum building into the back half of the year, with management forecasting organic subscription growth to pick up from mid-single digits toward higher single digits in the coming quarters.
- Are margins preserved while investing in AI? Non-GAAP operating margin remained at 34.3% in the quarter, even as free cash flow rose 81%, indicating the company retained profitability while allocating investment resources to AI initiatives.
- Does Salesforce retain a competitive moat? The Anthropic collaboration plus the integrated suite of Sales Cloud, Service Cloud, Slack, and Data Cloud were cited as durable differentiation within the enterprise stack.
Upcoming catalysts
Several near-term and medium-term events could validate or challenge the narrative:
- Near-term (30-90 days): Dreamforce is expected to highlight Agentforce version 4, a new IT Service Management platform, and expanded Claudeforce product details - turning demos into potential order streams. Management also said that the Contentful and financial technology acquisitions are expected to begin contributing incrementally to cRPO growth starting in Q3.
- Medium-term (Q3-Q4 FY2027): Management anticipates organic subscription growth to accelerate from around 6% in Q2 to approximately 7.1% in Q3 and about 8.4% in Q4 if guidance holds. A ramp in sales productivity could amplify revenue as ramped Account Executives increased 15 to 17% entering the fiscal year, and that cohort has had time to mature toward full productivity. Additionally, revenue recognition from a $5.6 billion U.S. Army contract remains ahead, with milestone-based payments expected across FY2027 and FY2028.
Street reaction and analyst positioning
Analysts reacted with generally constructive but varied stances. Representative positions included:
- Jefferies - Buy, $300 target; highlighted the first cRPO beat in three quarters and assigned a valuation reference of 13x CY27 EV/FCF.
- TD Cowen - Buy, $280 target; labeled the Anthropic tie-up as a significant trajectory event.
- Mizuho - Outperform, $265 target; pointed to cRPO momentum and the AI ARR inflection.
- Cantor Fitzgerald - Overweight, $250 target; cited highest net new annualized order value (NNAOV) in four years.
- Wells Fargo - Equal Weight, $230 target; acknowledged solid results but withheld a full upgrade pending clearer organic growth proof.
Bear case and watchpoints
Important uncertainties remain. Organic subscription growth was roughly 6% in constant currency for Q2, below TD Cowen’s circa 7% estimate and leaving some skepticism intact. The stock had declined about 32% year-to-date before this quarter’s results, reflecting a significant level of investor skepticism. The Anthropic partnership, while strategically significant, will need to translate into measurable and recurring customer adoption rather than headline-driven interest. A key specific risk called out by market participants is if Q3 organic growth fails to re-accelerate as guided; in that scenario the AI monetization thesis could lose momentum even with a strong cRPO print.